LT4001B - Process for preparing transformed prokaryotic host cell, stable gene amplification in the chromosome dna of prokaryotic microorganisms - Google Patents

Process for preparing transformed prokaryotic host cell, stable gene amplification in the chromosome dna of prokaryotic microorganisms Download PDF

Info

Publication number: LT4001B
Authority: LT; Lithuania
Prior art keywords: dna; bacillus; strain; recipient; chromosome
Prior art date: 1987-02-27

Application number

LTIP1826A

Other languages

English (en)

Lithuanian (lt)

Inventor

Christiaan Albertus Vaneekelen

Johannes Cornelis Vanderlaan

Leonardus Johannes S Mulleners

Original Assignee

Gist Brocades Nv

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1987-02-27

Filing date

1994-01-28

Publication date

1996-06-25

Family has litigation

First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=8197582&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=LT4001(B) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.

1994-01-28 Application filed by Gist Brocades Nv filed Critical Gist Brocades Nv

1995-08-25 Publication of LTIP1826A publication Critical patent/LTIP1826A/xx

1996-06-25 Publication of LT4001B publication Critical patent/LT4001B/lt

Links

210000000349 chromosome Anatomy 0.000 title claims abstract description 53
210000004027 cell Anatomy 0.000 title claims description 88
238000004519 manufacturing process Methods 0.000 title abstract description 11
230000004544 DNA amplification Effects 0.000 title description 5
244000005700 microbiome Species 0.000 title description 5
108090000623 proteins and genes Proteins 0.000 claims abstract description 116
238000000034 method Methods 0.000 claims abstract description 62
108091028043 Nucleic acid sequence Proteins 0.000 claims abstract description 52
241000193830 Bacillus <bacterium> Species 0.000 claims abstract description 38
241000194108 Bacillus licheniformis Species 0.000 claims abstract description 30
108091005804 Peptidases Proteins 0.000 claims abstract description 30
102000035195 Peptidases Human genes 0.000 claims abstract description 22
108090000765 processed proteins & peptides Proteins 0.000 claims abstract description 21
229920001184 polypeptide Polymers 0.000 claims abstract description 20
102000004196 processed proteins & peptides Human genes 0.000 claims abstract description 20
239000013611 chromosomal DNA Substances 0.000 claims abstract description 17
108090000637 alpha-Amylases Proteins 0.000 claims abstract description 12
241000894007 species Species 0.000 claims abstract description 8
102000004139 alpha-Amylases Human genes 0.000 claims abstract description 6
229940024171 alpha-amylase Drugs 0.000 claims abstract description 6
108020004414 DNA Proteins 0.000 claims description 69
239000013612 plasmid Substances 0.000 claims description 56
239000003550 marker Substances 0.000 claims description 20
230000006798 recombination Effects 0.000 claims description 20
238000005215 recombination Methods 0.000 claims description 20
108090000790 Enzymes Proteins 0.000 claims description 19
102000004190 Enzymes Human genes 0.000 claims description 18
229940088598 enzyme Drugs 0.000 claims description 18
239000012634 fragment Substances 0.000 claims description 18
230000002759 chromosomal effect Effects 0.000 claims description 17
210000001236 prokaryotic cell Anatomy 0.000 claims description 17
108010065511 Amylases Proteins 0.000 claims description 16
108010022999 Serine Proteases Proteins 0.000 claims description 16
238000002744 homologous recombination Methods 0.000 claims description 15
230000006801 homologous recombination Effects 0.000 claims description 15
230000009466 transformation Effects 0.000 claims description 15
230000010076 replication Effects 0.000 claims description 14
230000003115 biocidal effect Effects 0.000 claims description 12
230000001788 irregular Effects 0.000 claims description 12
102000012479 Serine Proteases Human genes 0.000 claims description 11
230000004927 fusion Effects 0.000 claims description 11
102000013142 Amylases Human genes 0.000 claims description 8
235000019418 amylase Nutrition 0.000 claims description 8
239000004382 Amylase Substances 0.000 claims description 7
239000001963 growth medium Substances 0.000 claims description 5
238000002955 isolation Methods 0.000 claims description 5
239000002773 nucleotide Substances 0.000 claims description 5
125000003729 nucleotide group Chemical group 0.000 claims description 5
239000000523 sample Substances 0.000 claims description 5
238000012258 culturing Methods 0.000 claims description 4
150000001413 amino acids Chemical group 0.000 claims description 3
239000003139 biocide Substances 0.000 claims description 3
230000003625 amylolytic effect Effects 0.000 claims 2
210000003370 receptor cell Anatomy 0.000 claims 2
XXQGYGJZNMSSFD-UHFFFAOYSA-N 2-[2-(dimethylcarbamoyl)phenoxy]acetic acid Chemical compound CN(C)C(=O)C1=CC=CC=C1OCC(O)=O XXQGYGJZNMSSFD-UHFFFAOYSA-N 0.000 claims 1
102100022443 CXADR-like membrane protein Human genes 0.000 claims 1
230000000721 bacterilogical effect Effects 0.000 claims 1
239000004365 Protease Substances 0.000 abstract description 19
102100037486 Reverse transcriptase/ribonuclease H Human genes 0.000 abstract 1
229930193140 Neomycin Natural products 0.000 description 41
229960004927 neomycin Drugs 0.000 description 41
210000001938 protoplast Anatomy 0.000 description 27
239000013598 vector Substances 0.000 description 27
235000014469 Bacillus subtilis Nutrition 0.000 description 25
230000037431 insertion Effects 0.000 description 23
238000003780 insertion Methods 0.000 description 23
230000014509 gene expression Effects 0.000 description 17
239000000047 product Substances 0.000 description 13
230000000694 effects Effects 0.000 description 12
239000002609 medium Substances 0.000 description 12
229920001817 Agar Polymers 0.000 description 10
238000000855 fermentation Methods 0.000 description 10
230000004151 fermentation Effects 0.000 description 10
230000001105 regulatory effect Effects 0.000 description 10
239000008272 agar Substances 0.000 description 9
238000012216 screening Methods 0.000 description 9
102220572479 Protein tyrosine phosphatase type IVA 1_T13F_mutation Human genes 0.000 description 8
230000003321 amplification Effects 0.000 description 8
238000010367 cloning Methods 0.000 description 8
238000010276 construction Methods 0.000 description 8
238000003199 nucleic acid amplification method Methods 0.000 description 8
239000002253 acid Substances 0.000 description 7
150000007513 acids Chemical class 0.000 description 7
235000018102 proteins Nutrition 0.000 description 7
102000004169 proteins and genes Human genes 0.000 description 7
244000063299 Bacillus subtilis Species 0.000 description 6
239000000020 Nitrocellulose Substances 0.000 description 5
239000006285 cell suspension Substances 0.000 description 5
238000001962 electrophoresis Methods 0.000 description 5
239000000499 gel Substances 0.000 description 5
HNDVDQJCIGZPNO-UHFFFAOYSA-N histidine Natural products OC(=O)C(N)CC1=CN=CN1 HNDVDQJCIGZPNO-UHFFFAOYSA-N 0.000 description 5
230000010354 integration Effects 0.000 description 5
229920001220 nitrocellulos Polymers 0.000 description 5
108020004707 nucleic acids Proteins 0.000 description 5
102000039446 nucleic acids Human genes 0.000 description 5
150000007523 nucleic acids Chemical class 0.000 description 5
108091008146 restriction endonucleases Proteins 0.000 description 5
230000001131 transforming effect Effects 0.000 description 5
108010076119 Caseins Proteins 0.000 description 4
239000011543 agarose gel Substances 0.000 description 4
238000004458 analytical method Methods 0.000 description 4
239000003242 anti bacterial agent Substances 0.000 description 4
239000000872 buffer Substances 0.000 description 4
239000005018 casein Substances 0.000 description 4
BECPQYXYKAMYBN-UHFFFAOYSA-N casein, tech. Chemical compound NCCCCC(C(O)=O)N=C(O)C(CC(O)=O)N=C(O)C(CCC(O)=N)N=C(O)C(CC(C)C)N=C(O)C(CCC(O)=O)N=C(O)C(CC(O)=O)N=C(O)C(CCC(O)=O)N=C(O)C(C(C)O)N=C(O)C(CCC(O)=N)N=C(O)C(CCC(O)=N)N=C(O)C(CCC(O)=N)N=C(O)C(CCC(O)=O)N=C(O)C(CCC(O)=O)N=C(O)C(COP(O)(O)=O)N=C(O)C(CCC(O)=N)N=C(O)C(N)CC1=CC=CC=C1 BECPQYXYKAMYBN-UHFFFAOYSA-N 0.000 description 4
235000021240 caseins Nutrition 0.000 description 4
230000001413 cellular effect Effects 0.000 description 4
239000003795 chemical substances by application Substances 0.000 description 4
230000002068 genetic effect Effects 0.000 description 4
238000009396 hybridization Methods 0.000 description 4
239000000203 mixture Substances 0.000 description 4
235000015097 nutrients Nutrition 0.000 description 4
238000002360 preparation method Methods 0.000 description 4
238000012163 sequencing technique Methods 0.000 description 4
238000012360 testing method Methods 0.000 description 4
CSCPPACGZOOCGX-UHFFFAOYSA-N Acetone Chemical compound CC(C)=O CSCPPACGZOOCGX-UHFFFAOYSA-N 0.000 description 3
108091005658 Basic proteases Proteins 0.000 description 3
108020004705 Codon Proteins 0.000 description 3
WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 3
PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 3
WHUUTDBJXJRKMK-VKHMYHEASA-N L-glutamic acid Chemical compound OC(=O)[C@@H](N)CCC(O)=O WHUUTDBJXJRKMK-VKHMYHEASA-N 0.000 description 3
102000003960 Ligases Human genes 0.000 description 3
108090000364 Ligases Proteins 0.000 description 3
KDXKERNSBIXSRK-UHFFFAOYSA-N Lysine Natural products NCCCCC(N)C(O)=O KDXKERNSBIXSRK-UHFFFAOYSA-N 0.000 description 3
239000004472 Lysine Substances 0.000 description 3
239000007993 MOPS buffer Substances 0.000 description 3
102000016943 Muramidase Human genes 0.000 description 3
108010014251 Muramidase Proteins 0.000 description 3
108010062010 N-Acetylmuramoyl-L-alanine Amidase Proteins 0.000 description 3
HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 description 3
229940088710 antibiotic agent Drugs 0.000 description 3
244000052616 bacterial pathogen Species 0.000 description 3
230000008901 benefit Effects 0.000 description 3
230000015572 biosynthetic process Effects 0.000 description 3
229940041514 candida albicans extract Drugs 0.000 description 3
238000005119 centrifugation Methods 0.000 description 3
230000002255 enzymatic effect Effects 0.000 description 3
239000000284 extract Substances 0.000 description 3
239000008103 glucose Substances 0.000 description 3
238000011534 incubation Methods 0.000 description 3
229960000274 lysozyme Drugs 0.000 description 3
239000004325 lysozyme Substances 0.000 description 3
235000010335 lysozyme Nutrition 0.000 description 3
238000012986 modification Methods 0.000 description 3
230000004048 modification Effects 0.000 description 3
210000004165 myocardium Anatomy 0.000 description 3
238000001556 precipitation Methods 0.000 description 3
230000028327 secretion Effects 0.000 description 3
239000006152 selective media Substances 0.000 description 3
239000006228 supernatant Substances 0.000 description 3
230000004083 survival effect Effects 0.000 description 3
239000012138 yeast extract Substances 0.000 description 3
229920000936 Agarose Polymers 0.000 description 2
108010088751 Albumins Proteins 0.000 description 2
102000009027 Albumins Human genes 0.000 description 2
241000304886 Bacilli Species 0.000 description 2
108090000145 Bacillolysin Proteins 0.000 description 2
241000588724 Escherichia coli Species 0.000 description 2
241001524679 Escherichia virus M13 Species 0.000 description 2
108091029865 Exogenous DNA Proteins 0.000 description 2
244000068988 Glycine max Species 0.000 description 2
235000010469 Glycine max Nutrition 0.000 description 2
101000740205 Homo sapiens Sal-like protein 1 Proteins 0.000 description 2
108010049190 N,N-dimethylcasein Proteins 0.000 description 2
108091005507 Neutral proteases Proteins 0.000 description 2
102000035092 Neutral proteases Human genes 0.000 description 2
108091034117 Oligonucleotide Proteins 0.000 description 2
102100037204 Sal-like protein 1 Human genes 0.000 description 2
MTCFGRXMJLQNBG-UHFFFAOYSA-N Serine Natural products OCC(N)C(O)=O MTCFGRXMJLQNBG-UHFFFAOYSA-N 0.000 description 2
FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 2
229920002472 Starch Polymers 0.000 description 2
108090000787 Subtilisin Proteins 0.000 description 2
108010056079 Subtilisins Proteins 0.000 description 2
102000005158 Subtilisins Human genes 0.000 description 2
JLCPHMBAVCMARE-UHFFFAOYSA-N [3-[[3-[[3-[[3-[[3-[[3-[[3-[[3-[[3-[[3-[[3-[[5-(2-amino-6-oxo-1H-purin-9-yl)-3-[[3-[[3-[[3-[[3-[[3-[[5-(2-amino-6-oxo-1H-purin-9-yl)-3-[[5-(2-amino-6-oxo-1H-purin-9-yl)-3-hydroxyoxolan-2-yl]methoxy-hydroxyphosphoryl]oxyoxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxyoxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methyl [5-(6-aminopurin-9-yl)-2-(hydroxymethyl)oxolan-3-yl] hydrogen phosphate Polymers Cc1cn(C2CC(OP(O)(=O)OCC3OC(CC3OP(O)(=O)OCC3OC(CC3O)n3cnc4c3nc(N)[nH]c4=O)n3cnc4c3nc(N)[nH]c4=O)C(COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3CO)n3cnc4c(N)ncnc34)n3ccc(N)nc3=O)n3cnc4c(N)ncnc34)n3ccc(N)nc3=O)n3ccc(N)nc3=O)n3ccc(N)nc3=O)n3cnc4c(N)ncnc34)n3cnc4c(N)ncnc34)n3cc(C)c(=O)[nH]c3=O)n3cc(C)c(=O)[nH]c3=O)n3ccc(N)nc3=O)n3cc(C)c(=O)[nH]c3=O)n3cnc4c3nc(N)[nH]c4=O)n3cnc4c(N)ncnc34)n3cnc4c(N)ncnc34)n3cnc4c(N)ncnc34)n3cnc4c(N)ncnc34)O2)c(=O)[nH]c1=O JLCPHMBAVCMARE-UHFFFAOYSA-N 0.000 description 2
230000002411 adverse Effects 0.000 description 2
238000005273 aeration Methods 0.000 description 2
238000003556 assay Methods 0.000 description 2
239000002299 complementary DNA Substances 0.000 description 2
239000012228 culture supernatant Substances 0.000 description 2
238000000605 extraction Methods 0.000 description 2
230000006870 function Effects 0.000 description 2
229960002989 glutamic acid Drugs 0.000 description 2
238000009776 industrial production Methods 0.000 description 2
230000000977 initiatory effect Effects 0.000 description 2
238000010369 molecular cloning Methods 0.000 description 2
230000035772 mutation Effects 0.000 description 2
YBYRMVIVWMBXKQ-UHFFFAOYSA-N phenylmethanesulfonyl fluoride Chemical compound FS(=O)(=O)CC1=CC=CC=C1 YBYRMVIVWMBXKQ-UHFFFAOYSA-N 0.000 description 2
238000007747 plating Methods 0.000 description 2
230000008569 process Effects 0.000 description 2
238000012545 processing Methods 0.000 description 2
230000035945 sensitivity Effects 0.000 description 2
238000011451 sequencing strategy Methods 0.000 description 2
239000008107 starch Substances 0.000 description 2
235000019698 starch Nutrition 0.000 description 2
239000000758 substrate Substances 0.000 description 2
YNJBWRMUSHSURL-UHFFFAOYSA-N trichloroacetic acid Chemical compound OC(=O)C(Cl)(Cl)Cl YNJBWRMUSHSURL-UHFFFAOYSA-N 0.000 description 2
XLYOFNOQVPJJNP-UHFFFAOYSA-N water Chemical compound O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 2
DGVVWUTYPXICAM-UHFFFAOYSA-N β‐Mercaptoethanol Chemical compound OCCS DGVVWUTYPXICAM-UHFFFAOYSA-N 0.000 description 2
108091032973 (ribonucleotides)n+m Proteins 0.000 description 1
101710151906 31 kDa protein Proteins 0.000 description 1
241001479434 Agfa Species 0.000 description 1
101710184263 Alkaline serine protease Proteins 0.000 description 1
102100034614 Ankyrin repeat domain-containing protein 11 Human genes 0.000 description 1
241000194107 Bacillus megaterium Species 0.000 description 1
241000194103 Bacillus pumilus Species 0.000 description 1
241000894006 Bacteria Species 0.000 description 1
108700003860 Bacterial Genes Proteins 0.000 description 1
239000002028 Biomass Substances 0.000 description 1
102000004506 Blood Proteins Human genes 0.000 description 1
108010017384 Blood Proteins Proteins 0.000 description 1
241000193417 Brevibacillus laterosporus Species 0.000 description 1
SGHZXLIDFTYFHQ-UHFFFAOYSA-L Brilliant Blue Chemical compound [Na+].[Na+].C=1C=C(C(=C2C=CC(C=C2)=[N+](CC)CC=2C=C(C=CC=2)S([O-])(=O)=O)C=2C(=CC=CC=2)S([O-])(=O)=O)C=CC=1N(CC)CC1=CC=CC(S([O-])(=O)=O)=C1 SGHZXLIDFTYFHQ-UHFFFAOYSA-L 0.000 description 1
OYPRJOBELJOOCE-UHFFFAOYSA-N Calcium Chemical compound [Ca] OYPRJOBELJOOCE-UHFFFAOYSA-N 0.000 description 1
240000001817 Cereus hexagonus Species 0.000 description 1
108091033380 Coding strand Proteins 0.000 description 1
241000195493 Cryptophyta Species 0.000 description 1
102000053602 DNA Human genes 0.000 description 1
108010054576 Deoxyribonuclease EcoRI Proteins 0.000 description 1
KCXVZYZYPLLWCC-UHFFFAOYSA-N EDTA Chemical compound OC(=O)CN(CC(O)=O)CCN(CC(O)=O)CC(O)=O KCXVZYZYPLLWCC-UHFFFAOYSA-N 0.000 description 1
241000196324 Embryophyta Species 0.000 description 1
101710089384 Extracellular protease Proteins 0.000 description 1
241000233866 Fungi Species 0.000 description 1
WHUUTDBJXJRKMK-UHFFFAOYSA-N Glutamic acid Natural products OC(=O)C(N)CCC(O)=O WHUUTDBJXJRKMK-UHFFFAOYSA-N 0.000 description 1
108060003951 Immunoglobulin Proteins 0.000 description 1
FFEARJCKVFRZRR-BYPYZUCNSA-N L-methionine Chemical compound CSCC[C@H](N)C(O)=O FFEARJCKVFRZRR-BYPYZUCNSA-N 0.000 description 1
GUBGYTABKSRVRQ-QKKXKWKRSA-N Lactose Natural products OC[C@H]1O[C@@H](O[C@H]2[C@H](O)[C@@H](O)C(O)O[C@@H]2CO)[C@H](O)[C@@H](O)[C@H]1O GUBGYTABKSRVRQ-QKKXKWKRSA-N 0.000 description 1
108010036940 Levansucrase Proteins 0.000 description 1
102000008072 Lymphokines Human genes 0.000 description 1
108010074338 Lymphokines Proteins 0.000 description 1
241000193386 Lysinibacillus sphaericus Species 0.000 description 1
241000124008 Mammalia Species 0.000 description 1
102000018697 Membrane Proteins Human genes 0.000 description 1
108010052285 Membrane Proteins Proteins 0.000 description 1
241000193418 Paenibacillus larvae Species 0.000 description 1
241000178960 Paenibacillus macerans Species 0.000 description 1
241000194105 Paenibacillus polymyxa Species 0.000 description 1
244000046052 Phaseolus vulgaris Species 0.000 description 1
235000010627 Phaseolus vulgaris Nutrition 0.000 description 1
239000004698 Polyethylene Substances 0.000 description 1
239000002202 Polyethylene glycol Substances 0.000 description 1
XBDQKXXYIPTUBI-UHFFFAOYSA-N Propionic acid Substances CCC(O)=O XBDQKXXYIPTUBI-UHFFFAOYSA-N 0.000 description 1
108010076504 Protein Sorting Signals Proteins 0.000 description 1
241000589516 Pseudomonas Species 0.000 description 1
240000004808 Saccharomyces cerevisiae Species 0.000 description 1
241000831652 Salinivibrio sharmensis Species 0.000 description 1
238000002105 Southern blotting Methods 0.000 description 1
241000187747 Streptomyces Species 0.000 description 1
229930006000 Sucrose Natural products 0.000 description 1
CZMRCDWAGMRECN-UGDNZRGBSA-N Sucrose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 CZMRCDWAGMRECN-UGDNZRGBSA-N 0.000 description 1
241000192707 Synechococcus Species 0.000 description 1
108020004566 Transfer RNA Proteins 0.000 description 1
239000007983 Tris buffer Substances 0.000 description 1
239000012042 active reagent Substances 0.000 description 1
238000000246 agarose gel electrophoresis Methods 0.000 description 1
239000012670 alkaline solution Substances 0.000 description 1
230000004075 alteration Effects 0.000 description 1
229940024606 amino acid Drugs 0.000 description 1
235000001014 amino acid Nutrition 0.000 description 1
229960000723 ampicillin Drugs 0.000 description 1
AVKUERGKIZMTKX-NJBDSQKTSA-N ampicillin Chemical compound C1([C@@H](N)C(=O)N[C@H]2[C@H]3SC([C@@H](N3C2=O)C(O)=O)(C)C)=CC=CC=C1 AVKUERGKIZMTKX-NJBDSQKTSA-N 0.000 description 1
229940025131 amylases Drugs 0.000 description 1
230000003698 anagen phase Effects 0.000 description 1
230000003254 anti-foaming effect Effects 0.000 description 1
238000010420 art technique Methods 0.000 description 1
IDIPWEYIBKUDNY-UHFFFAOYSA-N benzenesulfonyl fluoride Chemical compound FS(=O)(=O)C1=CC=CC=C1 IDIPWEYIBKUDNY-UHFFFAOYSA-N 0.000 description 1
108010019077 beta-Amylase Proteins 0.000 description 1
210000000941 bile Anatomy 0.000 description 1
238000011953 bioanalysis Methods 0.000 description 1
UDSAIICHUKSCKT-UHFFFAOYSA-N bromophenol blue Chemical compound C1=C(Br)C(O)=C(Br)C=C1C1(C=2C=C(Br)C(O)=C(Br)C=2)C2=CC=CC=C2S(=O)(=O)O1 UDSAIICHUKSCKT-UHFFFAOYSA-N 0.000 description 1
244000309464 bull Species 0.000 description 1
229910052791 calcium Inorganic materials 0.000 description 1
239000011575 calcium Substances 0.000 description 1
230000015556 catabolic process Effects 0.000 description 1
239000003153 chemical reaction reagent Substances 0.000 description 1
238000004587 chromatography analysis Methods 0.000 description 1
238000003776 cleavage reaction Methods 0.000 description 1
230000002860 competitive effect Effects 0.000 description 1
230000021615 conjugation Effects 0.000 description 1
230000001276 controlling effect Effects 0.000 description 1
238000012937 correction Methods 0.000 description 1
210000000805 cytoplasm Anatomy 0.000 description 1
231100000433 cytotoxic Toxicity 0.000 description 1
229940127089 cytotoxic agent Drugs 0.000 description 1
239000002254 cytotoxic agent Substances 0.000 description 1
231100000599 cytotoxic agent Toxicity 0.000 description 1
230000001472 cytotoxic effect Effects 0.000 description 1
239000007857 degradation product Substances 0.000 description 1
238000006731 degradation reaction Methods 0.000 description 1
238000012217 deletion Methods 0.000 description 1
230000037430 deletion Effects 0.000 description 1
239000003599 detergent Substances 0.000 description 1
238000010790 dilution Methods 0.000 description 1
239000012895 dilution Substances 0.000 description 1
238000009585 enzyme analysis Methods 0.000 description 1
210000003527 eukaryotic cell Anatomy 0.000 description 1
238000001914 filtration Methods 0.000 description 1
230000002538 fungal effect Effects 0.000 description 1
238000001502 gel electrophoresis Methods 0.000 description 1
238000010353 genetic engineering Methods 0.000 description 1
230000030414 genetic transfer Effects 0.000 description 1
235000013922 glutamic acid Nutrition 0.000 description 1
239000004220 glutamic acid Substances 0.000 description 1
230000012010 growth Effects 0.000 description 1
229910001385 heavy metal Inorganic materials 0.000 description 1
229940088597 hormone Drugs 0.000 description 1
239000005556 hormone Substances 0.000 description 1
230000036039 immunity Effects 0.000 description 1
102000018358 immunoglobulin Human genes 0.000 description 1
229940072221 immunoglobulins Drugs 0.000 description 1
238000000338 in vitro Methods 0.000 description 1
230000002779 inactivation Effects 0.000 description 1
230000001939 inductive effect Effects 0.000 description 1
239000003262 industrial enzyme Substances 0.000 description 1
208000015181 infectious disease Diseases 0.000 description 1
PGLTVOMIXTUURA-UHFFFAOYSA-N iodoacetamide Chemical compound NC(=O)CI PGLTVOMIXTUURA-UHFFFAOYSA-N 0.000 description 1
239000008101 lactose Substances 0.000 description 1
231100000518 lethal Toxicity 0.000 description 1
230000001665 lethal effect Effects 0.000 description 1
239000002502 liposome Substances 0.000 description 1
239000007788 liquid Substances 0.000 description 1
230000004807 localization Effects 0.000 description 1
238000012423 maintenance Methods 0.000 description 1
230000014759 maintenance of location Effects 0.000 description 1
230000035800 maturation Effects 0.000 description 1
230000007246 mechanism Effects 0.000 description 1
238000002844 melting Methods 0.000 description 1
230000008018 melting Effects 0.000 description 1
230000002503 metabolic effect Effects 0.000 description 1
229930182817 methionine Natural products 0.000 description 1
101150011281 mpl1 gene Proteins 0.000 description 1
238000002703 mutagenesis Methods 0.000 description 1
231100000350 mutagenesis Toxicity 0.000 description 1
210000005036 nerve Anatomy 0.000 description 1
230000008520 organization Effects 0.000 description 1
230000003204 osmotic effect Effects 0.000 description 1
230000002018 overexpression Effects 0.000 description 1
230000037361 pathway Effects 0.000 description 1
239000008188 pellet Substances 0.000 description 1
239000008363 phosphate buffer Substances 0.000 description 1
239000013600 plasmid vector Substances 0.000 description 1
229920002401 polyacrylamide Polymers 0.000 description 1
-1 polyethylene Polymers 0.000 description 1
229920000573 polyethylene Polymers 0.000 description 1
229920001223 polyethylene glycol Polymers 0.000 description 1
239000002244 precipitate Substances 0.000 description 1
239000013587 production medium Substances 0.000 description 1
108700022487 rRNA Genes Proteins 0.000 description 1
238000011084 recovery Methods 0.000 description 1
230000008929 regeneration Effects 0.000 description 1
238000011069 regeneration method Methods 0.000 description 1
230000022532 regulation of transcription, DNA-dependent Effects 0.000 description 1
230000008439 repair process Effects 0.000 description 1
230000003252 repetitive effect Effects 0.000 description 1
230000003362 replicative effect Effects 0.000 description 1
238000012552 review Methods 0.000 description 1
108020004418 ribosomal RNA Proteins 0.000 description 1
230000005070 ripening Effects 0.000 description 1
230000007017 scission Effects 0.000 description 1
238000005204 segregation Methods 0.000 description 1
235000020046 sherry Nutrition 0.000 description 1
239000011780 sodium chloride Substances 0.000 description 1
239000002689 soil Substances 0.000 description 1
230000002269 spontaneous effect Effects 0.000 description 1
230000028070 sporulation Effects 0.000 description 1
230000006641 stabilisation Effects 0.000 description 1
238000011105 stabilization Methods 0.000 description 1
239000008223 sterile water Substances 0.000 description 1
230000001954 sterilising effect Effects 0.000 description 1
238000004659 sterilization and disinfection Methods 0.000 description 1
238000003860 storage Methods 0.000 description 1
KDYFGRWQOYBRFD-UHFFFAOYSA-L succinate(2-) Chemical compound [O-]C(=O)CCC([O-])=O KDYFGRWQOYBRFD-UHFFFAOYSA-L 0.000 description 1
239000005720 sucrose Substances 0.000 description 1
239000000725 suspension Substances 0.000 description 1
238000003786 synthesis reaction Methods 0.000 description 1
230000005030 transcription termination Effects 0.000 description 1
230000002103 transcriptional effect Effects 0.000 description 1
238000012546 transfer Methods 0.000 description 1
238000013519 translation Methods 0.000 description 1
LENZDBCJOHFCAS-UHFFFAOYSA-N tris Chemical compound OCC(N)(CO)CO LENZDBCJOHFCAS-UHFFFAOYSA-N 0.000 description 1
POSZUTFLHGNLHX-KSBRXOFISA-N tris maleate Chemical compound OCC(N)(CO)CO.OCC(N)(CO)CO.OC(=O)\C=C/C(O)=O POSZUTFLHGNLHX-KSBRXOFISA-N 0.000 description 1
230000003612 virological effect Effects 0.000 description 1

Classifications

- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
- C12N9/14—Hydrolases (3)
- C12N9/24—Hydrolases (3) acting on glycosyl compounds (3.2)
- C12N9/2402—Hydrolases (3) acting on glycosyl compounds (3.2) hydrolysing O- and S- glycosyl compounds (3.2.1)
- C12N9/2405—Glucanases
- C12N9/2408—Glucanases acting on alpha -1,4-glucosidic bonds
- C12N9/2411—Amylases
- C12N9/2414—Alpha-amylase (3.2.1.1.)
- C12N9/2417—Alpha-amylase (3.2.1.1.) from microbiological source
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N1/00—Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
- C12N1/20—Bacteria; Culture media therefor
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
- C12N15/67—General methods for enhancing the expression
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
- C12N15/74—Vectors or expression systems specially adapted for prokaryotic hosts other than E. coli, e.g. Lactobacillus, Micromonospora
- C12N15/75—Vectors or expression systems specially adapted for prokaryotic hosts other than E. coli, e.g. Lactobacillus, Micromonospora for Bacillus
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/87—Introduction of foreign genetic material using processes not otherwise provided for, e.g. co-transformation
- C12N15/90—Stable introduction of foreign DNA into chromosome
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
- C12N9/14—Hydrolases (3)
- C12N9/48—Hydrolases (3) acting on peptide bonds (3.4)
- C12N9/50—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25)
- C12N9/52—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from bacteria or Archaea
- C12N9/54—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from bacteria or Archaea bacteria being Bacillus

Landscapes

Health & Medical Sciences (AREA)
Genetics & Genomics (AREA)
Life Sciences & Earth Sciences (AREA)
Engineering & Computer Science (AREA)
Chemical & Material Sciences (AREA)
Wood Science & Technology (AREA)
Zoology (AREA)
Bioinformatics & Cheminformatics (AREA)
Organic Chemistry (AREA)
Biotechnology (AREA)
Biomedical Technology (AREA)
General Engineering & Computer Science (AREA)
Molecular Biology (AREA)
Microbiology (AREA)
Biochemistry (AREA)
General Health & Medical Sciences (AREA)
Plant Pathology (AREA)
Biophysics (AREA)
Physics & Mathematics (AREA)
Medicinal Chemistry (AREA)
Mycology (AREA)
Tropical Medicine & Parasitology (AREA)
Virology (AREA)
Micro-Organisms Or Cultivation Processes Thereof (AREA)
Enzymes And Modification Thereof (AREA)
Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)

LTIP1826A 1987-02-27 1994-01-28 Process for preparing transformed prokaryotic host cell, stable gene amplification in the chromosome dna of prokaryotic microorganisms LT4001B (en)

Applications Claiming Priority (1)

Application Number	Priority Date	Filing Date	Title
EP87200356		1987-02-27

Publications (2)

Publication Number	Publication Date
LTIP1826A LTIP1826A (en)	1995-08-25
LT4001B true LT4001B (en)	1996-06-25

Family

ID=8197582

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
LTIP1826A LT4001B (en)	1987-02-27	1994-01-28	Process for preparing transformed prokaryotic host cell, stable gene amplification in the chromosome dna of prokaryotic microorganisms

Country Status (20)

Country	Link
US (2)	US5733723A (pt)
EP (1)	EP0284126B1 (pt)
JP (1)	JP2637532B2 (pt)
KR (1)	KR970000188B1 (pt)
CN (1)	CN1049247C (pt)
AU (1)	AU620326B2 (pt)
BG (1)	BG60920B2 (pt)
BR (1)	BR8805646A (pt)
CA (1)	CA1327175C (pt)
DE (1)	DE3883041T2 (pt)
ES (1)	ES2045081T3 (pt)
FI (1)	FI104326B1 (pt)
HU (1)	HUT50877A (pt)
IE (1)	IE61743B1 (pt)
LT (1)	LT4001B (pt)
LV (1)	LV10791B (pt)
NO (1)	NO300382B1 (pt)
PT (1)	PT86863B (pt)
RU (1)	RU2091487C1 (pt)
WO (1)	WO1988006623A1 (pt)

Families Citing this family (35)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
EP0896062A3 (en) *	1987-02-27	1999-04-07	Genencor International, Inc.	Transformation of alkalophilic bacillus strains
HUT50877A (en) *	1987-02-27	1990-03-28	Gist Brocades Nv	Process for producing stable gene amplification in chromosomal dna of procaryote microorganisms
US4914031A (en) *	1987-04-10	1990-04-03	Amgen, Inc.	Subtilisin analogs
US6287841B1 (en)	1988-02-11	2001-09-11	Genencor International, Inc.	High alkaline serine protease
DE69028890T2 (de) *	1989-08-11	1997-02-27	Gist Brocades Nv	Ergiebige Herstellung von Protease-Mutanten
US5695976A (en) *	1989-12-18	1997-12-09	Novo Nordisk A/S	Stable integration of DNA in bacterial genomes
JP3046344B2 (ja) *	1990-10-24	2000-05-29	塩野義製薬株式会社	新規プロテアーゼ
EP0672154A1 (en) *	1991-11-14	1995-09-20	Novo Nordisk A/S	A PROCESS FOR EXPRESSING GENES IN $i(BACILLUS LICHENIFORMIS)
DE4216246A1 (de) *	1992-05-16	1993-11-18	Solvay Enzymes Gmbh & Co Kg	Einfaches Verfahren zur stabilen chromosomalen Genamplifikation
US5395763A (en) *	1992-06-24	1995-03-07	Monsanto Company	Chromosomal expression vector
DK153992D0 (da) *	1992-12-22	1992-12-22	Novo Nordisk As	Metode
US5861273A (en) *	1993-12-21	1999-01-19	Celtrix Phamraceuticals, Inc.	Chromosomal expression of heterologous genes in bacterial cells
US6723550B1 (en)	1997-07-15	2004-04-20	Genencor International, Inc.	Proteases from gram-positive organisms
GB9724627D0 (en)	1997-11-20	1998-01-21	Genencor Int Bv	Gram positive microorganism formate pathway
GB9727470D0 (en)	1997-12-30	1998-02-25	Genencor Int Bv	Proteases from gram positive organisms
US6599731B1 (en)	1997-12-30	2003-07-29	Genencor International, Inc.	Proteases from gram positive organisms
US6465186B1 (en)	1997-12-30	2002-10-15	Genecor International, Inc.	Proteases from gram positive organisms
US6528255B1 (en)	1997-12-30	2003-03-04	Genencor International, Inc.	Proteases from gram positive organisms
US6100063A (en) *	1998-02-12	2000-08-08	Novo Nordisk A/S	Procaryotic cell comprising at least two copies of a gene
CN1160448C (zh) *	1998-02-12	2004-08-04	诺维信公司	含有两拷贝以不同方向转录之基因的原核细胞
RU2144565C1 (ru) *	1998-11-12	2000-01-20	Государственный научный центр вирусологии и биотехнологии "Вектор"	Рекомбинантная плазмидная днк pq_f35, кодирующая гибридный полипептид f 35, обладающий антигенными и иммуногенными свойствами белка vp 35 вируса марбург, способ ее получения и штамм бактерий escherichia coli - сверхпродуцент рекомбинантного полипептида f 35
US6156514A (en) *	1998-12-03	2000-12-05	Sunol Molecular Corporation	Methods for making recombinant cells
US6544792B1 (en)	1999-12-21	2003-04-08	Genencor International, Inc.	Production of secreted polypeptides
WO2002000907A1 (en) *	2000-06-23	2002-01-03	Novozymes A/S	Method for stable chromosomal multi-copy integration of genes
JP5244317B2 (ja)	2003-11-19	2013-07-24	ジェネンコー・インターナショナル・インク	セリンプロテアーゼ、セリン酵素をコードする核酸、およびこれらを取り込んだベクターおよび宿主細胞
US7985569B2 (en)	2003-11-19	2011-07-26	Danisco Us Inc.	Cellulomonas 69B4 serine protease variants
US20050227356A1 (en) *	2004-04-07	2005-10-13	Lessard Philip A	Novel compositions and methods for genetic manipulation of Rhodococcus bacteria
WO2006065272A2 (en) *	2004-05-21	2006-06-22	Idaho Research Foundation, Inc.	Methods for altering acetic acid production and enhancing cell death in bacteria
DK1766002T3 (en) *	2004-06-21	2015-12-07	Novozymes As	Stable maintenance of multiple copies of the at least two ORF in the same orientation
CN101061214B (zh)	2004-10-22	2012-12-05	诺维信公司	多个多核苷酸拷贝的稳定基因组整合
DE102007021001A1 (de)	2007-05-04	2008-11-06	Ab Enzymes Gmbh	Expressionssystem zur antibiotikafreien Produktion von Polypeptiden
CN103290048B (zh) *	2013-06-27	2015-07-15	天津科技大学	一种适用于芽孢杆菌属同源重组的质粒及工程菌
ES2855992T3 (es)	2015-12-11	2021-09-27	Wacker Chemie Ag	Cepa de microorganismos y procedimiento para la producción fermentativa exenta de antibióticos de sustancias y proteínas de bajo peso molecular
CN114032189B (zh) *	2021-05-10	2024-02-06	盐城师范学院	一种降解木质素的融合子菌株r3及其应用
GB202304540D0 (en)	2023-03-28	2023-05-10	Univ Tartu	Method of biosynthesis

Citations (1)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
EP0134048A1 (en)	1983-07-06	1985-03-13	Gist-Brocades N.V.	Molecular cloning and expression in industrial microorganism species

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US30602A (en) *		1860-11-06		Improvement in revolver fire-arms
GB1519148A (en) *	1974-11-19	1978-07-26	Gist Brocades Nv	Compositions of matter
NO159863C (no) *	1980-01-07	1989-02-15	Univ Rochester	Fremgangsm te for fremstilling og seleksjon av en rant bakteriofag som inneholder et genetisk fragment og koder for alfa-amylase, egnet for bruk i heterolog transformering av en bacillus-verts-mikroorganisme.
IL61982A (en) *	1980-02-15	1984-01-31	Cpc International Inc	Genetically engineered microorganisms for massive production of amyloytic enzymes and process for preparing same using the corresponding recombinant dnas containing amylase coding genes
EP0074553A3 (en) *	1981-09-11	1985-01-09	The University Of Rochester	Method of increasing the yield of a product by altering a microorganism
US4617266A (en) *	1983-04-28	1986-10-14	Genex Corporation	Production of Protein A
JPS59205983A (ja) *	1983-04-28	1984-11-21	ジエネツクス・コ−ポレイシヨン	異種遺伝子を原核微生物で発現させる方法
IE81141B1 (en) *	1983-06-24	2000-04-05	Genencor Int	Procaryotic carbonyl hydrolases
FR2563533B1 (fr) *	1984-04-27	1986-08-22	Centre Nat Rech Scient	Procede d'amplification de l'expression d'un gene determine chez bacillus subtilis et souches obtenues
US4828994A (en) *	1984-09-21	1989-05-09	Genex Corporation	Bacillus strains with reduced extracellular protease levels
FR2582316B1 (fr) *	1985-05-22	1988-12-02	Centre Nat Rech Scient	Vecteurs d'expression de l'a-amylase dans bacillus subtilis, souches obtenues et procede de preparation d'a-amylase
JP2599946B2 (ja) *	1986-01-15	1997-04-16	アムジェン，インコーポレイテツド	ズブチリシン類似体
HUT50877A (en) *	1987-02-27	1990-03-28	Gist Brocades Nv	Process for producing stable gene amplification in chromosomal dna of procaryote microorganisms

1988
- 1988-02-26 HU HU881833A patent/HUT50877A/hu unknown
- 1988-02-26 WO PCT/NL1988/000006 patent/WO1988006623A1/en not_active Ceased
- 1988-02-26 JP JP63502471A patent/JP2637532B2/ja not_active Expired - Lifetime
- 1988-02-26 AU AU13981/88A patent/AU620326B2/en not_active Expired
- 1988-02-26 PT PT86863A patent/PT86863B/pt not_active IP Right Cessation
- 1988-02-26 BR BR888805646A patent/BR8805646A/pt not_active Application Discontinuation
- 1988-02-26 RU SU884356795A patent/RU2091487C1/ru active
- 1988-02-27 CN CN88101680A patent/CN1049247C/zh not_active Expired - Lifetime
- 1988-02-29 EP EP88200376A patent/EP0284126B1/en not_active Revoked
- 1988-02-29 ES ES88200376T patent/ES2045081T3/es not_active Expired - Lifetime
- 1988-02-29 CA CA000560122A patent/CA1327175C/en not_active Expired - Lifetime
- 1988-02-29 DE DE88200376T patent/DE3883041T2/de not_active Revoked
- 1988-02-29 IE IE55888A patent/IE61743B1/en not_active IP Right Cessation
- 1988-10-05 NO NO884422A patent/NO300382B1/no unknown
- 1988-10-21 KR KR88701325A patent/KR970000188B1/ko not_active Expired - Lifetime
- 1988-10-24 FI FI884903A patent/FI104326B1/fi active IP Right Grant
- 1988-10-25 BG BG085832A patent/BG60920B2/bg unknown
1993
- 1993-12-08 LV LVP-93-1313A patent/LV10791B/en unknown
1994
- 1994-01-28 LT LTIP1826A patent/LT4001B/lt not_active IP Right Cessation
- 1994-08-24 US US08/295,082 patent/US5733723A/en not_active Expired - Lifetime
1998
- 1998-03-27 US US09/049,867 patent/US6124097A/en not_active Expired - Fee Related

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
EP0134048A1 (en)	1983-07-06	1985-03-13	Gist-Brocades N.V.	Molecular cloning and expression in industrial microorganism species

Non-Patent Citations (9)

* Cited by examiner, † Cited by third party
Title
ANDERSON RP, ROTH JR.: "Tandem genetic duplications in phage and bacteria.", ANNU REV MICROBIOL., 1977, pages 473 - 505
DEBADO: "Bacilų molekulinė biologija"
DUNCAN CH, WILSON GA, YOUNG FE.: "Mechanism of integrating foreign DNA during transformation of Bacillus subtilis", PROC NATL ACAD SCI U S A., 1978, pages 3664 - 3668, XP001313760
ERIC F. WAWROUSEK ET AL.: "Structure and organization of a cluster of sic tRNA genes in the space between tandem ribosomal RNA gene sets in Bacillus subtilis", J. BIOL. CHEM., 1983, pages 291 - 298
FERRARI E. ET AL.: "Isolation of an Alanine Racemase Gene from Bacillus subtilis and its Use for Plasmid Maintenance in B. subtilis", NATURE BIOTECHNOLOGY, 1985, pages 1003 - 1007
GAY P ET AL.: "Cloning structural gene sacB, which codes for exoenzyme levansucrase of Bacillus subtilis: expression of the gene in Escherichia coli.", J. BACTERIOL., 1983, pages 1424 - 1431, XP001297951
JANNIÈRE L ET AL.: "Stable gene amplification in the chromosome of Bacillus subtilis.", GENE, 1985, pages 47 - 55, XP023539816, DOI: doi:10.1016/0378-1119(85)90023-X
PALVA I. ET AL.: "Nucleotide sequence of the promoter and NH2-terminal signal peptide region of the alpha-amylase gene from Bacillus amyloliquefaciens.", GENE, 1981, pages 43 - 51, XP023542084, DOI: doi:10.1016/0378-1119(81)90103-7
YOUNG M.: "Gene amplification in Bacillus subtilis", J GEN MICROBIOL., 1984, pages 1613 - 1621, XP001206294

Also Published As

Publication number	Publication date
LTIP1826A (en)	1995-08-25
US6124097A (en)	2000-09-26
CA1327175C (en)	1994-02-22
PT86863B (pt)	1992-05-29
HUT50877A (en)	1990-03-28
FI884903A7 (fi)	1988-10-24
AU620326B2 (en)	1992-02-20
KR890700664A (ko)	1989-04-26
FI104326B (fi)	1999-12-31
ES2045081T3 (es)	1994-01-16
LV10791B (en)	1995-12-20
CN1030787A (zh)	1989-02-01
RU2091487C1 (ru)	1997-09-27
WO1988006623A1 (en)	1988-09-07
FI884903A0 (fi)	1988-10-24
EP0284126B1 (en)	1993-08-11
BR8805646A (pt)	1989-10-17
AU1398188A (en)	1988-09-26
PT86863A (pt)	1988-03-01
KR970000188B1 (en)	1997-01-06
FI104326B1 (fi)	1999-12-31
IE880558L (en)	1988-08-27
DE3883041D1 (de)	1993-09-16
JPH01502398A (ja)	1989-08-24
US5733723A (en)	1998-03-31
LV10791A (lv)	1995-08-20
NO884422L (no)	1988-10-05
JP2637532B2 (ja)	1997-08-06
NO300382B1 (no)	1997-05-20
EP0284126A1 (en)	1988-09-28
CN1049247C (zh)	2000-02-09
IE61743B1 (en)	1994-11-30
BG60920B2 (bg)	1996-06-28
NO884422D0 (no)	1988-10-05
DE3883041T2 (de)	1994-01-20

Publication	Publication Date	Title
LT4001B (en)	1996-06-25	Process for preparing transformed prokaryotic host cell, stable gene amplification in the chromosome dna of prokaryotic microorganisms
FI106726B (fi)	2001-03-30	Korkea-alkalisia proteaaseja koodaavien geenien transformointi Bacillus-bakteereihin, ja menetelmässä käytettävät vektorit, DNA-sekvenssit ja koettimet
EP0283075B1 (en)	1999-05-12	Molecular cloning and expression of genes encoding proteolytic enzymes
JPS61139392A (ja)	1986-06-26	形質転換された細菌による所望産物の製造方法
JPH08504585A (ja)	1996-05-21	Ｄｎａ増幅
US6100063A (en)	2000-08-08	Procaryotic cell comprising at least two copies of a gene
JP4350894B2 (ja)	2009-10-21	異なる方向に転写される２コピーの遺伝子を含有する原核細胞
Cheung et al.	1985	Two control systems modulate the level of glutaminyl-tRNA synthetase in Escherichia coli
EP0900271B1 (en)	2002-07-17	Bacterial donor cell useful in conjugation
US5763187A (en)	1998-06-09	Bacterial donor cell useful in conjugation
Nishise et al.	1986	Glycerol dehydrogenase of a protoplast fusant of Cellulomonas sp. NT3060
EP0303668A1 (en)	1989-02-22	Stable expression vectors

Legal Events

Date	Code	Title	Description
1998-09-25	MM9A	Lapsed patents	Effective date: 19980128